Phase II Study of GW572016 (NSC-727989) as First Line Therapy in Patients With Advanced or Metastatic Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2013
At a glance
- Drugs Lapatinib (Primary)
- Indications Gastric cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Apr 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 04 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.